Free shipping over $200.00Free 5 mL bacteriostatic water over $200.00

Metabolic Research

GLP3 30 mg

$169.00$249.0099.6% purity · Batch RT30-260610

Triple-agonist research peptide studied for GIP, GLP-1 and glucagon receptor activity in metabolic models.

1
  • Third-party HPLC & mass-spec verified
  • Same-day dispatch before 2 PM ET
  • Cold-packed, tamper-sealed shipping
  • Batch-coded and dated at fill

Research background

Retatrutide is investigated in preclinical metabolic literature for its combined action across three incretin receptor pathways. Supplied lyophilised in a sealed, batch-coded vial with a matching third-party HPLC certificate of analysis.

Research use only. This product is supplied strictly for in-vitro laboratory research by qualified professionals. It is not a drug, food or cosmetic and must not be administered to humans or animals.

Lot analysis for this batch

Lot
RT30-260610
Purity (3 vials)
99.68 / 99.68 / 99.62 %
Content (3 vials)
35.74 / 35.65 / 35.47 mg
Endotoxin
6.488 EU/vial
Tested by
Janoshik Analytical, Jun 2026

This analysis was commissioned by the manufacturer that supplies the material, and is published unedited.

Specifications

Molecular formula
C221H342N46O68
Molar mass
4731.4 g/mol
Form
Lyophilised white powder
Storage
-20 °C, protect from light
Certificate of analysis
View batch RT30-260610

More in Metabolic Research